|
Biopartnering Strategies: Maximizing returns from biotechnology deal-making
Biopartnering Strategies is a unique report from the Drug Discovery series that provides an essential guide to the biopartnering process, for both in-licensing and out-licensing companies. Detailed case studies of biopartnering strategies at different phases of lifecycle development and in-depth analysis of deal trends will ensure that you can identify best practice alliance and licensing strategies and formulate successful deals. Use this report to implement the optimal biopartnering strategy for your company’s needs as it progresses through the pioneer, growth and consolidation stages of the lifecycle and ensure you recognize opportunities for growth in this high profit market.
View
Table Of Contents >
|
